Outpatient parenteral antimicrobial therapy in pediatrics: an opportunity to expand antimicrobial stewardship

Elizabeth D Knackstedt1, Chris Stockmann1, Carly R Davis1

  • 1Division of Infectious Diseases,Department of Pediatrics,University of Utah,Salt Lake City,Utah.

Insights

Many pediatric patients receiving outpatient parenteral antimicrobial therapy (OPAT) may not need it or could have received modified treatment. This review highlights potential improvements in antimicrobial stewardship for children

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Healthcare Quality Improvement

Background:

  • Outpatient parenteral antimicrobial therapy (OPAT) is common in pediatric care.
  • Assessing the appropriateness of OPAT is crucial for optimizing patient outcomes and resource utilization.
  • Previous studies have indicated variability in OPAT appropriateness across different healthcare settings.

Purpose of the Study:

  • To evaluate the necessity and modifiability of OPAT in pediatric patient discharges.
  • To identify opportunities for improving antimicrobial prescribing and management in the outpatient setting.
  • To quantify the proportion of OPAT episodes that were potentially unnecessary or could be modified.

Main Methods:

  • Retrospective review of patient discharge data.
  • Analysis of all pediatric cases receiving OPAT.
  • Assessment of treatment recommendations by a multidisciplinary team.

Main Results:

  • A significant majority of OPAT episodes (78%) were identified as potentially modifiable.
  • Over 40% of OPAT cases were deemed potentially unnecessary.
  • Recommendations for modification or discontinuation were frequent across reviewed cases.

Conclusions:

  • There are substantial opportunities to optimize the use of OPAT in pediatric populations.
  • Implementing targeted interventions can improve the appropriateness of pediatric OPAT.
  • Enhanced antimicrobial stewardship programs are essential for reducing unnecessary OPAT.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
367
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
508
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
937
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
882